House Bill 1245
2023-2024 Regular Session
An Act amending the act of April 14, 1972 (P.L.233, No.64), known as The Controlled Substance, Drug, Device and Cosmetic Act, further providing for definitions and for prohibited acts and penalties.
Co-Sponsorship Memo
Prime Sponsor
Representative Sara Innamorato
D House District 21
Co-Sponsors
Rep. James Struzzi
R House District 62
Rep. Tarik Khan
D House District 194
Rep. MaryLouise Isaacson
D House District 175
Rep. Michael Schlossberg
D House District 132
Rep. Emily Kinkead
D House District 20
Rep. Joseph Hohenstein
D House District 177
Rep. Benjamin Sanchez
D House District 153
Rep. Jared Solomon
D House District 202
Rep. John Galloway
D House District 140
Rep. Rick Krajewski
D House District 188
Rep. Abigail Salisbury
D House District 34
Rep. David Delloso
D House District 162
Rep. Stephen Kinsey
D House District 201
Rep. Maureen Madden
D House District 115
Rep. Carol Hill-Evans
D House District 95
Rep. Dan Frankel
D House District 23
Rep. Melissa Cerrato
D House District 151
Rep. Ismail Smith-Wade-El
D House District 49
Rep. Melissa Shusterman
D House District 157
Rep. Malcolm Kenyatta
D House District 181
Rep. Ben Waxman
D House District 182
Rep. Mandy Steele
D House District 33
Rep. G. Roni Green
D House District 190
Rep. Chris Pielli
D House District 156
Rep. Greg Vitali
D House District 166
Rep. Jeanne McNeill
D House District 133
Bill Status & History
Last Action: Laid on the table, March 18, 2024
House
H
S
| 1345 | Referred to Judiciary, May 24, 2023 |
| Reported as committed, March 18, 2024 | |
| First consideration, March 18, 2024 | |
| Laid on the table, March 18, 2024 |
Printers Numbers
Votes
Wednesday, February 14, 2024
House JUDICIARY Committee Vote
House JUDICIARY Committee Vote - House Bill 1245 PN1345, Report Bill As Committed - opens in a new tab
House JUDICIARY Committee Vote - House Bill 1245 PN1345, Report Bill As Committed - opens in a new tab
Committee Meetings
Voting meeting on HB 1245, HB 1678, HB 1806, HR 211, SB 55 and any other business that may come before the committee.
Voting meeting on HB 1245, HB 1678, HB 1806, HR 211, SB 55 and any other business that may come before the committee.
Statute References
This bill amends the act of April 14, 1972 (P.L.0233, No.64), known as the Controlled Substance, Drug, Device And Cosmetic Act, The. Other bills amending the same statute are listed below.
Rep. Carol Hill-Evans
D House District 95
Rep. Doyle Heffley
R House District 122
Rep. Carl Metzgar
R House District 69
Only the first 5 bills are included here. Looking for more?
View all legislation amending the act of
April 14, 1972 (P.L.0233, No.64), known as the Controlled Substance, Drug, Device And Cosmetic Act, The - opens in a new tab
House Bill 1245
2023-2024 Regular Session
Sponsors
INNAMORATO, STRUZZI, KHAN, ISAACSON, SCHLOSSBERG, KINKEAD, HOHENSTEIN, SANCHEZ, SOLOMON, GALLOWAY, KRAJEWSKI, SALISBURY, DELLOSO, KINSEY, MADDEN, HILL-EVANS, FRANKEL, CERRATO, SMITH-WADE-EL, SHUSTERMAN, KENYATTA, WAXMAN, STEELE, GREEN, PIELLI, VITALI, McNEILL
Short Title
An Act amending the act of April 14, 1972 (P.L.233, No.64), known as The Controlled Substance, Drug, Device and Cosmetic Act, further providing for definitions and for prohibited acts and penalties.
Memo Subject
Criminalizing illicit possession of xylazine, with veterinary use exemptions
Actions
| 1345 | Referred to JUDICIARY, May 24, 2023 |
| Reported as committed, March 18, 2024 | |
| First consideration, March 18, 2024 | |
| Laid on the table, March 18, 2024 |
Generated 07/08/2024 02:13 PM